Patent · US Active

Systems and methods for assessing a likelihood of CTEPH and identifying characteristics indicative thereof

US12002203B2 · kind B2 · utility

0Cited by

28References

21Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Karym EL SAYED · Berlin, DE
Henry Hernaez · Pittsburgh, US
Nivitha Mahesh · Murrysville, US
Wei-Hsuan Liao · Frankfurt am Main, DE
Franco Fois · Monheim, DE
Daniel Rechsteiner · Cologne, DE
Jacob Agris · Great Neck, US
Mohammad Sedigh Ghamari · Jersey City, US
Xiangzhen Gao · Sterling Heights, US
Prahlad Menon Gopalakrishna · Pittsburgh, US

Key dates

Filing date	Mar 10, 2020
Grant date	Jun 4, 2024
Priority date	—
Expiry date	Feb 21, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG06T2207/30061
WIPO fieldComputer technology
WIPO sectorElectrical engineering

Abstract

Described are systems and methods for assessing a likelihood of chronic thromboembolic pulmonary hypertension (CTEPH) within a subject patient based upon an analysis of characteristics indicative of chronic thromboembolic pulmonary hypertension within an imaging study of the subject patient. The systems and methods can identify characteristics of one or more anatomical structures within a cardiac region of the subject patient indicative of CTEPH, characteristics of a pulmonary vasculature of the subject patient indicative of CTEPH, and characteristics of a chronic abnormality in a lung of the subject patient indicative of CTEPH. The systems and methods can assess these characteristics to compute the likelihood of CTEPH within the subject patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.